The Place of Eluxadoline in the Management of Irritable Bowel Syndrome With Diarrhea

Therapeutic Advances in Gastroenterology - United Kingdom
doi 10.1177/1756283x17721152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Eluxadoline in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Clinical Potential of Eluxadoline in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

Therapeutics and Clinical Risk Management
2016English

Understanding the Rome IV: Irritable Bowel Syndrome and Functional Diarrhea

The Korean Journal of Medicine
2017English

Guidelines on the Management of Irritable Bowel Syndrome

Przeglad Gastroenterologiczny
Gastroenterology
2018English

Diet in the Pathophysiology and Management of Irritable Bowel Syndrome

Cleveland Clinic Journal of Medicine
Medicine
2016English

The Irritable Bowel Syndrome.

Postgraduate Medical Journal
Medicine
1997English

Management Options for Irritable Bowel Syndrome

Mayo Clinic Proceedings
Medicine
2018English

Review: Optimizing Outcomes With Alosetron Hydrochloride in Severe Diarrhea-Predominant Irritable Bowel Syndrome

Therapeutic Advances in Gastroenterology
Gastroenterology
2010English

Luminal and Mucosal-Associated Intestinal Microbiota in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

Gut Pathogens
VirologyParasitologyInfectious DiseasesMicrobiologyGastroenterology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy